2 - Magnolia B - Infectious Disease
-
Register
- Non-member - Free!
- Member - Free!
Already registered?
Log in now.
| 2:45 PM | Samantha Sallerson, The Unity Hospital of Rochester | Evaluation of MRSA surveillance on the empiric treatment of pneumonia at a community teaching hospital |
| 3:00 PM | Andrew Hepler, Summit Health | Daptomycin Substituted for Vancomycin in Skin and Skin Structure Infections: An Assessment of Clinical Outcomes and Cost |
| 3:15 PM | Romina Javadi, St. Barnabas - Bronx | Impact of a Pharmacy-Driven Vancomycin Monitoring Program at SBH Health System |
| 3:30 PM | Thuan Tran, Cambridge Health Alliance | The Nose Knows: Utility of MRSA Nasal PCR Screening for Antimicrobial Stewardship at Two Community-Teaching Hospitals |
| 3:45 PM | Anna Chen, James J Peters Veterans Affairs Medical Center | Timing of corticosteroid initiation in relation to symptom onset in severe COVID-19 |
| 4:00 PM | Michael Lichardi, Ocean University Medical Center | Evaluation of a Pharmacist to Dose Vancomycin Pilot Program in a University Medical Center Critical Care Unit |
| 4:15 PM | Andrew Wallin, Englewood Hospital and Medical Center | Casirivimab plus Imdevimab versus Bamlanivimab Monotherapy versus Bamlanivimab plus Etesevimab: Effect on 30-day Hospitalizations for COVID-19 at a Community Hospital |
| 4:30 PM | Sydney Petersen, West Virginia University Medicine | Frequency of therapeutic drug monitoring and occurrence of acute kidney injury (AKI) for patients receiving vancomycin on an outpatient parenteral antibiotic therapy (OPAT) program |
Samantha Sallerson
Andrew Hepler
Romina Javadi
Thuan Tran
Anna Chen
Michael Lichardi
Andrew Wallin
Sydney Petersen
Alexander Cain (Moderator)
Complete
Next
Failed
Available
Locked